Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389869![]() (4-{5-[3-(2,4-Difluorophenyl)- 3H-imidazo[4,5-c]pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389878![]() (4-({4-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389912![]() (5-[3-(4-Chloro-2-fluorophenyl)- 3H-imidazo[4,5-c]p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389914![]() (N-(1-{5-[3-(4-Chlorophenyl)-3H-imidazo[4,5-c]pyrid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389933![]() ((2R,6S)-2,6-Dimethyl-4-{5-[3- (5-methylpyridin-2-y...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389944![]() (1-Cyclopropyl-4-[3-(4-fluorophenyl)-3H-imidazo[4,5...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389972![]() (4-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389978![]() (5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389837![]() (N-(Cyclopropylmethyl)-5-[3-(4- fluorophenyl)-3H-im...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389884![]() (4-{5-[3-(4-Fluoro-2- methylphenyl)-3H-imidazo[4,5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389918![]() (1-{5-[3-(4-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389962![]() (4-{5-[1-(4-Bromophenyl)-1H- pyrrolo[2,3-c]pyridin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389974![]() (6-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389871![]() (N-(2-Ethoxyethyl)-5-[3-(4- methylphenyl)-3H-imidaz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389875![]() (1-({4-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389894![]() (4-{2-[6-(Morpholin-4-yl)pyridin- 3-yl]-3H-imidazo[...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389836![]() (1-{5-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389898![]() (5-[3-(4-Fluorophenyl)-3H- imidazo[4,5-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389899![]() (4-{5-[3-(4-Fluorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389913![]() (5-[3-(4-Chloro-2-fluorophenyl)- 3H-imidazo[4,5-c]p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389957![]() (4-{5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389865![]() (N-(3-Methoxypropyl)-5-[3-(4- methylphenyl)-3H-imid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389879![]() (1-{5-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389890![]() (4-{5-[3-(2-Chloro-4- fluorophenyl)-3H-imidazo[4,5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389832![]() (4-{6-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389896![]() (4-{5-[3-(2-Fluoro-4- methylphenyl)-3H-imidazo[4,5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389904![]() (4-{5-[3-(5-Chloropyridin-2-yl)- 3H-imidazo[4,5-c]p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389907![]() (4-{5-[3-(2,4-Difluorophenyl)- 3H-imidazo[4,5-c]pyr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389942![]() (5-[3-(4-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-y...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389947![]() ((2R,6S)-2,6-Dimethyl-4-{5-[3- (6-methylpyridin-3-y...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389966![]() (5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389967![]() (4-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389969![]() (4-({5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389976![]() (4-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389839![]() (5-[3-(4-Chlorophenyl)-3H- imidazo[4,5-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389850![]() (4-{5-[3-(4-Chloro-2- fluorophenyl)-3H-imidazo[4,5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389853![]() (4-{5-[3-(4-Fluorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389855![]() (4-{5-[3-(4-Chloro-2- fluorophenyl)-3H-imidazo[4,5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389910![]() (4-{5-[3-(5-Chloropyridin-2-yl)- 3H-imidazo[4,5-c]p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389915![]() (1-(4-{5-[3-(4-Fluorophenyl)-3H-imidazo[4,5-c]pyrid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389919![]() (4-{5-[3-(4-Chlorophenyl)-3H-imidazo[4,5-c]pyridin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389928![]() (5-[3-(4-Fluorophenyl)-3H- imidazo[4,5-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389958![]() (4-{5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389963![]() (5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389968![]() (5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389977![]() (3-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389852![]() (4-{5-[3-(4-Fluorophenyl)-3H- imidazo[4,5-c]pyridin...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389916![]() (1-(4-{5-[3-(4-Fluorophenyl)-3H-imidazo[4,5-c]pyrid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389950![]() (2-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular adhesion protein 1 (VAP-1) (Homo sapiens (Human)) | BDBM389955![]() (5-[1-(4-Chlorophenyl)-1H- pyrrolo[2,3-c]pyridin-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
PROXIMAGEN LIMITED US Patent | Assay Description SSAO: All primary assays were performed at RT. with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in Öhma... | US Patent US9951068 (2018) BindingDB Entry DOI: 10.7270/Q2W0989F | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 213 total ) | Next | Last >> |